Traditional Chinese medicine composition for treating hyperplasia of mammary glands and application thereof

By using topical preparations and self-heating patches of traditional Chinese medicine compositions, direct local application, the inconvenience and side effects of oral medication in breast hyperplasia treatment were solved, and more efficient and safer treatment effects were achieved.

CN118976091AInactive Publication Date: 2024-11-19NINGBO HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411471333.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-22
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing treatment methods for breast hyperplasia mainly rely on oral Chinese medicine, which have problems such as poor taste, gastrointestinal reactions, liver and kidney function damage and difficult treatment, especially for young women, it is difficult to effectively treat it.

Method used

Provide a traditional Chinese medicine composition including safflower, Nanxing, black aconite, cinnamon, raw ephedra, ginger, fried white mustard and green skin, used to prepare topical drugs or Chinese medicine self-heating patches, directly locally, avoid oral administration, combined with infrared rays Physical therapy to improve efficacy.

Benefits of technology

This method does not require oral administration, which reduces the burden on the gastrointestinal tract and liver and kidneys, is convenient to dosage, only 1 to 2 times a week, each dosing time is short, has good efficacy, and has a low incidence of local allergies and rashes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention provides a traditional Chinese medicine composition for treating hyperplasia of mammary glands and application thereof, and belongs to the field of traditional Chinese medicine preparations, the traditional Chinese medicine composition provided by the invention comprises the following components: safflower, prepared arisaema consanguineum schott, black monkshood, cinnamon, raw ephedra, baked ginger, fried semen brassicae and pericarpium citri reticulatae viride. More specifically, the traditional Chinese medicine composition is prepared from the following components in parts by mass: 8-15 parts of flos carthami, 8-15 parts of processed rhizoma arisaematis, 10-18 parts of black radix aconiti lateralis preparata, 7-10 parts of cortex cinnamomi, 10-18 parts of raw herba ephedrae, 17-20 parts of baked ginger, 5-10 parts of fried semen brassicae and 8-15 parts of pericarpium citri reticulatae viride. The traditional Chinese medicine composition provided by the invention is used as an external medicine for hyperplasia of mammary glands, has no burden on gastrointestinal tract, liver and kidney, and is a good alternative treatment scheme for patients who are unwilling to orally take medicines to treat hyperplasia of mammary glands.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of Chinese medicine preparations, and in particular to a Chinese medicine composition for treating breast hyperplasia and application thereof. Background Art

[0002] Fibrocystic breast disease is a common and frequently occurring disease of female breasts, which is more common in women aged 25 to 45 years old. Currently, the treatment of this disease is mainly based on oral administration of traditional Chinese medicine or Chinese patent medicine, which needs to be taken orally and absorbed through the gastrointestinal tract to take effect. It has disadvantages such as poor taste, continuous administration, gastrointestinal reactions, liver and kidney function damage, and cumbersome and time-consuming decoction of traditional Chinese medicine. Young women in particular find it difficult to persist in taking the medicine and interrupt the treatment, affecting the overall treatment effect. Summary of the invention

[0003] The purpose of the present invention is to provide a drug for breast hyperplasia that is simple to use and has little side effects.

[0004] To achieve the above objectives, the first aspect of the present invention provides a Chinese medicine composition for treating breast hyperplasia, comprising the following components: safflower, processed arisaema, black aconite root, cinnamon bark, raw ephedra, roasted ginger, fried white mustard seeds, and green peel.

[0005] In the traditional Chinese medicine composition provided by the present invention, safflower is used for promoting blood circulation, removing blood stasis and relieving pain; processed arisaema is used for dispersing nodules, reducing swelling and relieving pain; black aconite is used for warming yang, dispersing cold and relieving pain; cinnamon is used for replenishing fire and yang, dispersing cold and relieving pain; raw ephedra is used for dispersing cold and reducing swelling; roasted ginger is used for warming the middle, dispersing cold and relieving pain; fried white mustard is used for resolving phlegm, dispersing nodules and unblocking meridians; and green peel is used for soothing the liver, breaking up qi, promoting qi and relieving pain.

[0006] Preferably, the above-mentioned traditional Chinese medicine composition includes 8-15 parts of safflower, 8-15 parts of processed arisaema, 10-18 parts of black aconite, 7-11 parts of cinnamon, 10-18 parts of raw ephedra, 17-20 parts of roasted ginger, 5-10 parts of stir-fried white mustard seeds, and 8-15 parts of green peel.

[0007] Preferably, by weight, the above-mentioned traditional Chinese medicine composition includes 11 parts of safflower, 11 parts of processed arisaema, 13 parts of black aconite, 9 parts of cinnamon, 13 parts of raw ephedra, 19 parts of roasted ginger, 8 parts of stir-fried white mustard seeds, and 11 parts of green peel.

[0008] Preferably, the following components are included by mass: 8 parts of safflower, 8 parts of processed arisaema, 10 parts of black aconite, 7 parts of cinnamon, 10 parts of raw ephedra, 17 parts of roasted ginger, 5 parts of fried white mustard seeds, and 8 parts of green peel.

[0009] Preferably, the following components are included by mass: 15 parts of safflower, 15 parts of processed arisaema, 18 parts of black aconite, 11 parts of cinnamon, 15 parts of raw ephedra, 20 parts of roasted ginger, 10 parts of fried white mustard seeds, and 13 parts of green peel.

[0010] Preferably, the following components are included by mass: 9 parts of safflower, 9 parts of processed arisaema, 11 parts of black aconite, 8 parts of cinnamon, 11 parts of raw ephedra, 18 parts of roasted ginger, 6 parts of fried white mustard seeds, and 9 parts of green peel.

[0011] Preferably, the following components are included by mass: 14 parts of safflower, 14 parts of processed arisaema, 17 parts of black aconite, 11 parts of cinnamon, 15 parts of raw ephedra, 19 parts of roasted ginger, 8 parts of fried white mustard seeds, and 12 parts of green peel.

[0012] Furthermore, the second aspect of the present invention provides an application of the Chinese medicine composition described in the first aspect, that is, the Chinese medicine composition is used for the preparation of a breast hyperplasia drug, and the breast hyperplasia drug is used to treat breast hyperplasia or breast pain caused by liver depression, qi stagnation, phlegm coagulation, blood stasis or Chong and Ren disorders.

[0013] Preferably, the breast hyperplasia drug is an external preparation. The breast hyperplasia drug provided by the present invention is an external preparation, which does not need to be taken orally when used, avoids the first-pass effect of the active ingredients of the drug, and has the advantages of good therapeutic effect and convenient administration.

[0014] Preferably, the external preparation is selected from ointment, liniment, water injection, and moxibustion Chinese medicine powder.

[0015] Furthermore, the third aspect of the present invention provides a method for preparing a Chinese medicine self-heating patch for treating breast hyperplasia, which specifically comprises the following steps: S1: after mixing vermiculite and water, add water-absorbing resin and mix again; S2: adding sodium chloride, carbon powder and iron powder to the mixture prepared in step S1 and mixing; S3: Add the Chinese medicine composition described in the first aspect to the mixture prepared in step S2, mix well and package to obtain a Chinese medicine self-heating patch for treating breast hyperplasia.

[0016] In the above preparation method, iron powder is mainly used to synthesize polymers with other ingredients in the self-heating patch (such as activated carbon, water, etc.), and react with oxygen in the air to generate heat to make the self-heating patch generate heat. Vermiculite is a thermal insulation material that can effectively prolong the heating time of the self-heating patch and achieve a good warming effect.

[0017] Preferably, the mass ratio of the water, vermiculite, water-absorbing resin, sodium chloride, carbon powder, iron powder and the traditional Chinese medicine composition is 2:(1-3):2:3:(4-5):(6-8):5.

[0018] Furthermore, the fourth aspect of the present invention provides a Chinese medicine self-heating patch for treating breast hyperplasia, which is prepared by the preparation method described in the third aspect.

[0019] Compared with the prior art, the present invention has the following beneficial effects: when the Chinese medicine composition provided by the present invention is used to treat breast hyperplasia, it does not need to be taken orally, acts locally directly, does not burden the gastrointestinal tract and the liver and kidneys, and is a good alternative treatment for patients who are unwilling to take oral medication to treat breast hyperplasia. At the same time, when the Chinese medicine composition provided by the present invention is used to treat breast hyperplasia, it only needs to be administered 1 to 2 times a week, and the shortest administration time for each administration is only 20 minutes, which has a good therapeutic effect. DETAILED DESCRIPTION

[0020] In order to make the above-mentioned purposes, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below. It should be noted that the following embodiments are only used to illustrate the implementation method and typical parameters of the present invention, and are not used to limit the parameter range described in the present invention. Reasonable changes derived therefrom are still within the scope of protection of the claims of the present invention.

[0021] It should be noted that the endpoints and any values ​​of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of each range, the endpoint values ​​of each range and the individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, and these numerical ranges should be regarded as specifically disclosed in this article.

[0022] Unless otherwise defined, all terms, symbols and other scientific terms used herein are intended to have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. In some cases, terms with commonly understood meanings are defined herein for the purpose of clarification or ease of reference, and such definitions herein should not be construed as indicating significant differences from the commonly understood meanings in the art. The technical methods described or cited herein are generally well understood by those skilled in the art and are adopted by conventional methods.

[0023] As described in the prior art, the commonly used Chinese medicine for treating breast hyperplasia is an oral preparation and the therapeutic effect and side effects cannot be guaranteed. Based on this, the specific embodiment of the present invention provides a Chinese medicine composition for treating breast hyperplasia and its application. The Chinese medicine composition includes the following components: safflower, processed arisaema, black aconite, cinnamon bark, raw ephedra, roasted ginger, fried white mustard seeds, and green peel.

[0024] In the above embodiment, the following components are included by mass: 8-15 parts of safflower, 8-15 parts of processed arisaema, 10-18 parts of black aconite, 7-10 parts of cinnamon, 10-18 parts of raw ephedra, 17-20 parts of roasted ginger, 5-10 parts of stir-fried white mustard seeds, and 8-15 parts of green peel.

[0025] The Chinese medicine composition provided in the above embodiment can be used for the preparation of drugs for breast hyperplasia. The preparation method is specifically completed by the following steps: mix and grind safflower, processed arisaema, black aconite, cinnamon, raw ephedra, roasted ginger, fried white mustard, and green peel according to a suitable ratio, and pack them into bags. Put boiling water and the powder in a stainless steel tank and mix them evenly into a medicine paste to obtain a drug preparation for the treatment of breast hyperplasia. The method of using the drug preparation is: spread the drug preparation on a disposable cotton towel, the area of ​​the spread medicine paste should be larger than the area of ​​the patient's breast, the thickness should be moderate and uniform, when the temperature is suitable, let the patient fully expose the breast, place the cotton towel on the patient's breast, and at the same time irradiate the breast with an infrared therapy lamp at a suitable distance for 20 minutes, and then remove the disposable cotton towel containing Chinese medicine.

[0026] The above embodiment is prepared by using Chinese medicine with the effect of "soothing the liver and resolving phlegm, warming and dispersing nodules". In the above prescription, fried white mustard seeds resolve phlegm, dispersing nodules and unblocking the meridians, processed arisaema dispersing nodules, relieving swelling and relieving pain, and black aconite dispersing cold and relieving pain play the effects of warming the meridians and unblocking the meridians, resolving phlegm and dispersing nodules, and are the main medicine; raw ephedra dispersing cold and relieving swelling, roasted ginger warms the middle and relieves pain, cinnamon warms the middle and dispersing cold, regulating qi and relieving pain, and enhancing the effect of warming and dispersing nodules, and are the ministerial medicine; safflower promotes blood circulation and dissipates blood stasis, dispersing nodules and relieving pain, and assists in the effect of dispersing blood stasis and dispersing nodules, and is the adjuvant medicine; green peel soothes the liver and breaks qi, promotes qi and relieves pain, and assists the whole prescription to enter the liver meridian to improve the efficacy of the whole prescription, and is the guiding medicine. The above Chinese medicine composition has good effects in clinical use, and the incidence of local allergies and rashes is extremely low.

[0027] The technical solution of the present invention is further described below through specific implementation methods.

[0028] Example 1

[0029] The proportions of the Chinese medicine composition used in this embodiment are as follows by mass: 11 parts of safflower, 11 parts of processed arisaema, 13 parts of black aconite, 9 parts of cinnamon bark, 13 parts of raw ephedra, 19 parts of roasted ginger, 8 parts of stir-fried white mustard seeds, and 11 parts of green peel.

[0030] Ding, female, 30 years old, was admitted to the outpatient clinic on February 15, 2024 for "repeated breast pain before menstruation for 2 years". The patient had breast pain after ovulation and before menstruation for two years, which was obvious when touched, and the breast mass was thickened. Color Doppler ultrasound showed breast hyperplasia. Current symptoms: breast swelling before menstruation, disappearing after menstruation, and the patient was worried and worried. The patient did not want to take Chinese medicine for treatment. She was given Chinese medicine powder for external application twice a week. After 2 weeks of treatment, the patient's breast pain and discomfort were significantly improved.

[0031] Example 2

[0032] By mass, the proportion of the Chinese medicine composition used in this embodiment is: 8 parts of safflower, 8 parts of processed arisaema, 10 parts of black aconite, 7 parts of cinnamon, 10 parts of raw ephedra, 17 parts of roasted ginger, 5 parts of stir-fried white mustard seeds, and 8 parts of green peel.

[0033] Zhang, female, 39 years old, first diagnosed on March 22, 2024, main complaint: recurrent breast pain for 3 weeks. Current medical history: The patient complained of breast pain and discomfort after getting angry 3 weeks ago, and ultrasound showed: breast hyperplasia. Breast pain, worse before menstruation, and irritability at ordinary times. Treated with Chinese medicine powder applied externally once a week, after 1 month, the pain and discomfort of both breasts improved significantly.

[0034] Example 3

[0035] The proportions of the Chinese medicine composition used in this embodiment are as follows by mass: 15 parts of safflower, 15 parts of processed arisaema, 18 parts of black aconite, 11 parts of cinnamon bark, 15 parts of raw ephedra, 20 parts of roasted ginger, 10 parts of stir-fried white mustard seeds, and 13 parts of green peel.

[0036] Zhu, female, 42 years old, first diagnosed on February 23, 2024, chief complaint: recurrent breast pain for 1 year. Current medical history: The patient complained of breast pain and discomfort every 10-14 days before menstruation for 1 year. Color Doppler ultrasound showed: poor breast structure on both sides (BI-RADS 2 category), low echo area on the left breast (considered hyperplastic gland). Twice a week, Chinese medicine powder was applied externally. After 1 month, the premenstrual breast pain and discomfort were significantly improved, and there was no obvious pain.

[0037] Example 4

[0038] By mass, the proportion of the Chinese medicine composition used in this embodiment is: 9 parts of safflower, 9 parts of processed arisaema, 11 parts of black aconite, 8 parts of cinnamon, 11 parts of raw ephedra, 18 parts of roasted ginger, 6 parts of stir-fried white mustard seeds, and 9 parts of green peel.

[0039] Qi, female, 40 years old, first diagnosed on March 10, 2024, chief complaint: repeated breast pain for 3 years, aggravated for more than 2 months. Current medical history: The patient complained of breast pain without obvious cause 3 years ago, worse premenstrual pain, and irritability. In the past two months, she felt that breast pain was worse than before, accompanied by a decrease in menstrual volume. Breast color Doppler ultrasound showed: breast hyperplasia in both breasts, ultrasound BI-RADS classification 1. Traditional Chinese medicine diagnosis: breast addiction (liver depression and phlegm condensation syndrome), Western medicine diagnosis: breast hyperplasia. Treated with Chinese medicine powder twice a week, after 1 month, the discomfort of premenstrual breast pain was significantly improved.

[0040] Example 5

[0041] By mass, the proportion of the Chinese medicine composition used in this embodiment is: 14 parts of safflower, 14 parts of processed arisaema, 17 parts of black aconite, 11 parts of cinnamon, 15 parts of raw ephedra, 19 parts of roasted ginger, 8 parts of stir-fried white mustard seeds, and 12 parts of green peel.

[0042] Wang, female, 26 years old, visited the hospital on March 17, 2024, with the main complaint: breast pain for 1 month. Current medical history: The patient has felt breast pain without obvious cause in the past month, and the pain has gradually worsened. Self-administration of Rupi Sanjie Granules has not significantly relieved the pain. Color Doppler ultrasound shows: disordered breast gland structure, uneven internal echoes, multiple small nodules in both breasts, and ultrasound BI-RADS classification III. Traditional Chinese medicine diagnosis: Rupi (liver depression and phlegm condensation syndrome), Western medicine diagnosis: breast hyperplasia. Treated with external application of Chinese medicine powder twice a week, after 1 month, breast pain and discomfort were significantly improved.

[0043] Example 6

[0044] Preparation method of Chinese medicine self-heating patch First, add vermiculite and water into a beaker and mix thoroughly, then add water-absorbing resin and mix again, and after ensuring that the mixture is evenly mixed, continue to add sodium chloride, carbon powder and iron powder, and ensure that the mixture is evenly mixed each time. Add 5g of the subpackaged powder, and the mass of water, vermiculite, water-absorbing resin, sodium chloride, carbon powder, iron powder and Chinese medicine composition is prepared according to Table 1.

[0045] Table 1

[0046] The heating time above 40°C and the maximum temperature of the self-heating patches of groups 1 to 18 were measured. The results are shown in Table 2.

[0047] Table 2

[0048] In summary, the self-heating patch provided by the present invention has a more suitable maximum temperature and a longer high temperature duration as a patch. The optimal mass fractions of each component in the self-heating patch are 2 parts of water, 2 parts of vermiculite, 3 parts of water-absorbing resin, 3 parts of sodium chloride, 4 parts of carbon powder, and 7 parts of iron powder.

[0049] Example 7

[0050] 80 patients with breast hyperplasia who visited the Department of Thyroid and Breast Surgery of Ningbo Traditional Chinese Medicine Hospital from October 2022 to December 2023 were collected. The clinical syndrome was liver depression and phlegm coagulation type. All patients were enrolled according to the inclusion and exclusion criteria and divided into a treatment group and a control group using a random number table method, 40 cases in each group. After a 2-month treatment course, clinical observation was performed before and after treatment. The experiment described in this embodiment has been approved by the Ethics Committee of Ningbo Traditional Chinese Medicine Hospital.

[0051] Disease diagnosis refers to the diagnostic criteria for breast hyperplasia in the "Expert Consensus on Diagnosis and Treatment of Breast Hyperplasia" adopted by the Women's Health Branch of the Chinese Association of Preventive Medicine in 2016: (1) Breast pain: related to the menstrual cycle, with pain aggravated before menstruation and relieved after menstruation; or non-cyclic pain; (2) Thickening of the breast glands can be palpated, which may be localized or diffuse throughout the breast; some granular or cord-like nodules may be palpable; symptoms and signs may vary with the menstrual cycle; (3) Nipple discharge may be seen occasionally, usually in light yellow, colorless or milky white, and rarely bloody; or nipple itching may occur; (4) Others: Some patients may also experience symptoms such as menstrual disorders, mood swings, irritability, etc. (5) Auxiliary examinations: Breast Doppler ultrasound, breast X-ray examination, puncture biopsy, etc. are helpful for diagnosis.

[0052] The disease diagnosis also refers to the liver depression and qi stagnation type breast disease in the "Standards for Diagnosis and Efficacy of TCM Diseases and Syndromes" revised in 2017 and the liver depression and phlegm stagnation syndrome standard in the "Tenth Edition of TCM Surgery": (1) Main symptoms: The incidence rate is higher in young and middle-aged women; the main manifestation is breast pain, which may be accompanied by distending pain, tingling, etc. The symptoms may change with the menstrual cycle and mood; some patients may feel a firm breast lump on palpation; (2) Secondary symptoms: ① Distension and discomfort in the chest and flanks; ② Emotional frustration, depression and anger; ③ Feeling upset and bitter in the mouth; (3) Tongue: red or light red, with a thin white, thin yellow or greasy coating; (4) Pulse: wiry or slippery.

[0053] TCM syndrome differentiation diagnostic criteria: patients with main symptoms and any two or more secondary symptoms.

[0054] This study adopted a random grouping method, and 80 patients were numbered 001-080, and random data were generated through Excel tables. They were divided into a treatment group and a control group using a random number table method, with 40 cases in each group, and then the corresponding treatment was performed in each group. Among them, there were 40 cases in the treatment group and 40 cases in the control group. Before and after treatment, both groups of patients filled in the case report form as required, including pain visualization VAS table, Cardiff daily pain record form, breast pain score, main breast symptoms and TCM symptom score, breast color ultrasound gland thickness and elasticity score, sex hormone level, etc.

[0055] The experiment was divided into a treatment group and a control group. The treatment group was treated with a combination of self-heating patches and oral medications, while the control group was treated with oral medications. The specific groups are as follows.

[0056] Treatment Group: Use of Chinese medicine self-heating patch: During operation, the patient directly opens the outer package and takes out the heating patch. The midpoint of the application is the most obvious part of the breast pain. After peeling off the anti-allergic adhesive of the self-heating patch, apply it on the breast, so that the side exposed to the Chinese medicine powder directly contacts the skin. Discard it after 30 minutes of hot compress each time. Apply once every 2 days for a course of 2 months.

[0057] The Chinese medicine self-heating patch mainly includes a self-heating material layer, a Chinese medicine raw material layer, an anti-allergic adhesive patch, a microporous breathable non-woven fabric laminate, and inner and outer packaging bags. The materials of the self-heating layer are mainly high-purity iron powder, sodium chloride, activated carbon, and vermiculite. The heating principle is that activated carbon can effectively absorb moisture in the air, causing iron to undergo an oxidation-reduction reaction in humid air. At the same time, the reaction is accelerated by ionization chemical corrosion under the catalysis of salt (NaCl), thereby releasing sufficient heat in a relatively short period of time. After being roasted by the heat released by the oxidation of iron powder, the mineral vermiculite expands rapidly in volume, producing a large number of fine air interlayers that can store a large amount of air, thereby reducing the speed of heat transfer inside the material, reducing the loss of heat energy, and prolonging the duration of heating, which plays a role in heat preservation. The self-heating material layer adopts a microporous non-woven film with good moisture permeability and air permeability as the backing material, the purpose is to ensure that the air enters the self-heating material for smooth oxidation while isolating it to avoid direct contact with the skin causing allergies or burns; the double-sided interlayer design, the above-mentioned self-heating materials are mixed in a specified proportion and then put in, the edges are hot-pressed and sealed to prevent leakage, each self-heating patch needs to weigh 12g of the Chinese medicine composition of Example 1, the amount ratio of vermiculite, water-absorbing resin, sodium chloride, carbon powder, and iron powder is loaded according to Group 1 in Example 6, and sealed and packaged with a 10*8cm microporous breathable film non-woven bag for standby use, and the back is covered with a self-heating material layer to form a main functional layer; then the medical pressure-sensitive adhesive is used to bond the surface of the functional layer, and the edge of the adhesive surface leaves about 2cm of the adhesive larger than the size of the functional layer for pasting on the skin, and then the anti-adhesive film is covered on the surface of the functional layer, and bonded to the adhesive surface of the medical pressure-sensitive adhesive, and sealed in a dry airtight plastic bag. The size of each finished product is about 12*10cm, and one bag contains 2 pieces that can be used to treat both breasts.

[0058] Oral medication: Oral administration of Rupi Sanjie Granules from Shaanxi Bailu Pharmaceutical Co., Ltd., National Medicine Standard Z20080206, product specification 4g / bag. Usage and dosage: Take with 150ml warm water, 3 times a day, 1 bag each time, half an hour to one hour after a meal, the course of treatment is 2 months.

[0059] Control group: Orally take Rupi Sanjie Granules of Shaanxi Bailu Pharmaceutical Co., Ltd., National Medicine Standard Z20080206, product specification 4g / bag. Usage and dosage: Take with 150ml warm water, 3 times a day, 1 bag each time, half an hour to one hour after meals, the course of treatment is 2 months.

[0060] Test results: All patients in this study were patients with liver depression and phlegm stagnation type breast hyperplasia who visited the outpatient clinic of the Department of Thyroid and Breast Surgery of Ningbo Hospital of Traditional Chinese Medicine from October 2022 to December 2023. A total of 80 subjects were included in this study, and there were no dropout cases.

[0061] The maximum age of the two groups of patients was 50 years old, and the minimum age was 20 years old. The average age of the treatment group and the control group was 35.00±8.33 / 35.15±7.73, respectively. The maximum number of pregnancies was 3, the minimum was 0, and the average number of pregnancies in both groups was 1. The maximum number of previous miscarriages was 2, the minimum was 0, and the average number of previous miscarriages in both groups was 0. The maximum number of births was 3, the minimum was 0, and the average number of births in both groups was 1. The longest breastfeeding time was 14 months, the shortest breastfeeding time was 0 months, and the average breastfeeding time in the two groups was 4 months and 4.5 months, respectively. The comparison of the age, pregnancy, previous miscarriage, birth, and breastfeeding history between the two groups was not statistically significant (P>0.05), indicating that the baseline data of the two groups of patients before treatment were at the same level, and the experiment was comparable.

[0062] Objective evaluation index of breast pain was used to evaluate the objective evaluation index of breast pain (VSA), with 0 to 10 indicating the degree of breast pain, and both groups of patients scored before and after treatment. Objective evaluation index of breast pain (VSA) was used to evaluate the objective evaluation index of breast pain (VSA), with 0 to 10 indicating the degree of breast pain, and both groups of patients scored before and after treatment.

[0063] The Wilcoxon signed-rank test and Mann-Whitney U test showed that there was no significant difference in VAS scores between the two groups before treatment ( P >0.05, the two groups of patients were comparable. Compared with before treatment, the VAS scores of the two groups of patients decreased after treatment ( P< 0.05) and the VAS score in the treatment group was lower than that in the control group ( P< 0.05), indicating that the treatment group has better efficacy than the control group. The specific experimental results are shown in Table 3.

[0064] Table 3

[0065] Two-way repeated measures analysis of variance was performed, and the results of the Mochley sphericity test showed that the Cardiff daily pain scores of the two groups of patients before and after treatment were consistent with the sphericity test ( x 2 =5.334, P =0.069), there was a main effect of time in the comparison of Cardiff daily pain scores between the two groups before and after treatment ( F =277.232, P <0.001), interaction effect of group and time ( F =4.989, P =0.008) and the main effect of group ( F =7.818, P=0.007). Compared with the first day of enrollment, the Cardiff daily pain scores of both groups decreased after one month of treatment ( P <0.05), compared with the 1-month treatment, the Cardiff daily pain scores of the two groups of patients continued to decrease after 2 months of treatment, and the difference was statistically significant ( P <0.05, it can be considered that both treatment measures in the two groups have the effect of relieving breast pain. There was no statistically significant difference in the Cardiff daily pain scores between the two groups on the first day of enrollment ( P< 0.05). After 1 month and 2 months of treatment, the Cardiff daily pain scores in the treatment group were lower than those in the control group, and the difference was statistically significant ( P< 0.05), indicating that the treatment group was better than the control group in relieving breast pain. See Table 4 for specific results.

[0066] Table 4

[0067] The Mann-Whitney U test showed that before treatment, the two groups had relatively consistent baseline scores for breast-related symptoms, including breast pain grade, lump hardness, lump range, maximum diameter of the lump, and total score of breast-related symptoms, with no statistically significant differences ( P >0.05), which is comparable. The Wilcoxon signed rank test found that compared with before treatment, the breast pain grade, lump hardness, lump range, and total score of breast-related symptoms in the control group after treatment were all reduced, and the difference was statistically significant ( P< 0.05); however, there was no statistically significant difference in the maximum diameter of the tumor before and after treatment ( P >0.05). See Table 5 for specific results.

[0068] Table 5

[0069] It can be seen from the above that the Chinese medicine composition provided by the present invention and the corresponding self-heating patch for treating breast hyperplasia have good therapeutic effects.

[0070] Although the disclosure is disclosed as above, the protection scope of the disclosure is not limited thereto. Those skilled in the art can make various changes and modifications without departing from the spirit and scope of the disclosure, and these changes and modifications will fall within the protection scope of the present invention.

Claims

1. A Chinese medicine composition for treating breast hyperplasia, characterized in that: The invention comprises the following components by weight: 8-15 parts of safflower, 8-15 parts of processed arisaema, 10-18 parts of black aconite, 7-11 parts of cinnamon bark, 10-18 parts of raw ephedra, 17-20 parts of roasted ginger, 5-10 parts of stir-fried white mustard seeds and 8-15 parts of green peel.

2. The Chinese medicine composition according to claim 1, characterized in that The invention comprises the following components by weight: 11 parts of safflower, 11 parts of processed arisaema, 13 parts of black aconite root, 9 parts of cinnamon bark, 13 parts of raw ephedra, 19 parts of roasted ginger, 8 parts of fried white mustard seeds and 11 parts of green peel.

3. The Chinese medicine composition according to claim 1, characterized in that: The invention comprises the following components by weight: 8 parts of safflower, 8 parts of processed arisaema, 10 parts of black aconite root, 7 parts of cinnamon bark, 10 parts of raw ephedra, 17 parts of roasted ginger, 5 parts of fried white mustard seeds and 8 parts of green peel.

4. The Chinese medicine composition according to claim 1, characterized in that: The invention comprises the following components by weight: 15 parts of safflower, 15 parts of processed arisaema, 18 parts of black aconite root, 11 parts of cinnamon bark, 15 parts of raw ephedra, 20 parts of roasted ginger, 10 parts of fried white mustard seeds and 13 parts of green peel.

5. The Chinese medicine composition according to claim 1, characterized in that: The invention comprises the following components by weight: 9 parts of safflower, 9 parts of processed arisaema, 11 parts of black aconite root, 8 parts of cinnamon bark, 11 parts of raw ephedra, 18 parts of roasted ginger, 6 parts of fried white mustard seeds and 9 parts of green peel.

6. The Chinese medicine composition according to claim 1, characterized in that: The invention comprises the following components by weight: 14 parts of safflower, 14 parts of processed arisaema, 17 parts of black aconite root, 11 parts of cinnamon bark, 15 parts of raw ephedra, 19 parts of roasted ginger, 8 parts of fried white mustard seeds and 12 parts of green peel.

7. An application of the Chinese medicine composition according to any one of claims 1 to 6, characterized in that: The Chinese medicine composition is used for the preparation of a breast hyperplasia drug, which is used to treat breast hyperplasia or breast pain caused by liver depression, qi stagnation, phlegm coagulation, blood stasis or Chong and Ren disorders. The breast hyperplasia drug is an external preparation selected from one of ointments, liniments, water injections and moxibustion Chinese medicine powders.

8. A method for preparing a Chinese medicine self-heating patch for treating breast hyperplasia, characterized in that: The following steps are involved: S1: after mixing vermiculite and water, add water-absorbing resin and mix again; S2: adding sodium chloride, carbon powder and iron powder to the mixture prepared in step S1 and mixing; S3: Add the Chinese medicine composition according to any one of claims 1 to 6 to the mixture prepared in step S2, mix well and package to obtain a Chinese medicine self-heating patch for treating breast hyperplasia.

9. The preparation method according to claim 8, characterized in that: The mass ratio of the water, vermiculite, water-absorbing resin, sodium chloride, carbon powder, iron powder and traditional Chinese medicine composition is 2:(1-3):2:(3-5):(4-5):(6-8):

5.

10. A Chinese medicine self-heating patch for treating breast hyperplasia, characterized in that: The preparation method is described in claim 8 or 9.

Citation Information

Patent Citations

  • Self-heating type mammary gland medical hot compress patch and preparation method thereof

    CN104984178A

  • Chinese medicinal composition for treating hyperplasia of mammary glands and preparation thereof

    CN109224042A

  • Hot-compress acupoint patch added with moxa powder and preparation method of hot-compress acupoint patch

    CN117159267A